Patents Assigned to EPSILEN BIO S.R.L
  • Publication number: 20240139319
    Abstract: An engineered transcriptional modulator (ETM) comprising: (a) at least one epigenetic effector domain; operably linked to (b) an endonuclease.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 2, 2024
    Applicant: EPSILEN BIO S.R.L
    Inventors: Angelo Leone Lombardo, Alice Reschigna, Tania Baccega